Web Stats Provided By Google Analytics

Monday, July 1, 2013

TNI BioTech, Inc., Concludes Type C Meeting at the FDA

... designed to harness the power of the immune system to improve the treatment of cancer, chronic infections such as HIV/AIDS, and autoimmune diseases and, such as Their proprietary technology, therapies, and patents are planned to treat a wide range ...

http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=23712

No comments:

Post a Comment